DailyIQ
Last updated1 minute ago

USMV·iShares MSCI USA Min Vol Factor ETF

$100.64
-0.01 (-0.01%)
After Hours
High
$100.68
Open
$100.44
Net Assets
$23.2B
52W High
—
Low
$100.28
P. Close
$100.64
Expense Ratio
0.15%
52W Low
—
Div. Yield
1.40%
Next Ex-Div
~Dec 15
Top 10 Weight
15.3%
Category
Large Blend
Inception
Oct 18, 2011
Technical Score (1D)
47
NEUTRAL
News Sentiment
48
MIXED

What's happening to USMV today?

On Oct 13, USMV’s holdings included JNJ, PEP, PG, and KO, each of which reported recent corporate developments. JNJ reported Q3 2026 results with worldwide sales of $25.4 billion, net earnings falling to $210 million due to a $7 billion talc settlement and a $1 billion Firefly Bio acquisition expense, and adjusted earnings per share dropping to $2.59, while its enterprise margin declined from 35.2% to 30.2%. JNJ also lifted its 2026 adjusted earnings guidance to $11.10 per share, though its adjusted earnings slipped 7.5% to $2.59 per share, and MedTech revenue growth lagged behind Innovative Medicine. PEP lowered its fourth‑quarter earnings guidance amid rising costs, but maintained a 54‑year dividend growth streak, with a forward dividend yield of about 4.7%. PG reported fiscal 2026 organic sales rising only 1% driven by pricing, and declared a quarterly dividend of $1.0885 per share, extending its 70‑year consecutive increase streak, while shareholders approved all director nominees and the executive compensation plan. KO celebrated its 63rd consecutive year of dividend increases to $0.53 per share, but paid $8.8 billion in dividends against $5.3 billion in free cash flow, raising concerns about future dividend sustainability. These developments illustrate the varied performance and dividend dynamics of USMV’s constituent holdings as of Oct 13.